ArticlesBiphasic Effects of Anandamide
Section snippets
Animals
Female Sabra mice (6–7 weeks old, Harlan–Sprague–Dawley, Jerusalem) were used for the open-field, ring test, body temperature, and hot-plate tests. Males of albino outbred ICR mice bred at VELAZ, Prague (8 weeks old), were used for the model of agonistic behavior. Female mice of the inbred strain C57BL/10 (8 weeks old) were used for testing of leukocyte phagocytic activity. Animals received food and water ad lib and were maintained at constant temperature (20–22°C) on a 12 L:12 D cycle. Tests
Results
A dose of 0.01 mg/kg of anandamide significantly increased ambulation and rearing, as well as defecation in the open-field (Fig. 1). This dose also decreased the rate of immobility on the ring (Fig. 2A). A nonsignificant tendency to decrease analgesia (Fig. 2B) on a hot plate was also observed, but body temperature was not affected by this dose (data not shown). A dose of 0.1 mg/kg did not elicit significant changes. Ten and 100 mg/kg markedly decreased activity in the open field, increased
Discussion
The inhibitory effects of high doses of anandamide in the various tests are in agreement with previous data 15, 40. In contrast, in most assays performed, a low dose (0.01 mg/kg) of anandamide had effects in the opposite direction to those found after high doses. Thus, we observed stimulated motor activity and rate of defecation in the open field, increased motility on the ring, and aggressive behavior in “timid” mice. Body temperature and analgesia were not significantly affected by low doses.
Acknowledgements
This work was supported by the Grant Agency of the Czech Republic to E. S. (grant No. 309/93/0165) and U.S. National Institute on Drug Abuse to R. M. (Grant Nos. 6481 and 9789).
References (50)
New hot plate tests to quantify antinocoception and narcotic antagonist activities
Eur. J. Pharmacol.
(1974)- et al.
Opioids can evoke direct receptor mediated excitatory effects on sensory neurons
Trends Pharmacol. Sci.
(1990) - et al.
Anandamide, and endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents
Pharmacol. Biochem. Behav.
(1993) - et al.
Cannabinoids enhance human B-cell growth at low nanomolar concentrations
FEBS Lett.
(1995) AnandamidesTolerance and cross-tolerance to delta 9-tetrahydrocannabinol
Brain Res.
(1995)- et al.
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
Eur. J. Pharmacol.
(1993) G-proteins and dual control of adenylate cyclase
Cell
(1984)- et al.
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
Pharmacol. Biochem. Behav.
(1991) - et al.
Search for endogenous ligands of the cannabinoid receptor
Biochem. Pharmacol.
(1994) - et al.
An endogenous cannabinoid as an endothelium derived vasorelaxant
Biochem. Biophys. Res. Commun.
(1996)